Mirum Pharmaceuticals, Inc. Common Stock MIRM
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-14T02:09:24.763Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T21:00:02.431697426Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-14T02:09:24.406806+00:00
Mirum Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 77.82 | 179.3% | 20.0% | |||
| 25Δ | 104.10 | 93.2% | 12.8% | 84.20 | 135.0% | 13.4% |
| 30Δ | 102.08 | 95.8% | 11.1% | |||
| 35Δ | 100.07 | 98.4% | 9.5% | 90.92 | 76.2% | 6.0% |
| 40Δ | 98.30 | 95.8% | 8.1% | 92.21 | 79.9% | 5.5% |
| 45Δ | 96.53 | 93.1% | 6.8% | 93.50 | 83.7% | 5.0% |
| 50Δ | 94.81 | 90.7% | 5.5% | 94.79 | 87.4% | 4.4% |
| 55Δ | 93.31 | 90.6% | 4.8% | 96.28 | 88.0% | 3.8% |
| 60Δ | 91.82 | 90.5% | 4.0% | 97.82 | 87.9% | 3.2% |
| 65Δ | 90.33 | 90.4% | 3.3% | 99.35 | 87.8% | 2.6% |
| 70Δ | 88.66 | 90.6% | 2.7% | 101.33 | 89.7% | 2.1% |
| 75Δ | 86.94 | 90.8% | 2.1% | 103.63 | 93.0% | 1.7% |
| 80Δ | 85.23 | 91.1% | 1.6% | 106.45 | 97.0% | 1.3% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 77.82
- IV
- 179.3%
- B/E move
- 20.0%
25Δ
- Pseudo strike
- 104.10
- IV
- 93.2%
- B/E move
- 12.8%
- Pseudo strike
- 84.20
- IV
- 135.0%
- B/E move
- 13.4%
30Δ
- Pseudo strike
- 102.08
- IV
- 95.8%
- B/E move
- 11.1%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 100.07
- IV
- 98.4%
- B/E move
- 9.5%
- Pseudo strike
- 90.92
- IV
- 76.2%
- B/E move
- 6.0%
40Δ
- Pseudo strike
- 98.30
- IV
- 95.8%
- B/E move
- 8.1%
- Pseudo strike
- 92.21
- IV
- 79.9%
- B/E move
- 5.5%
45Δ
- Pseudo strike
- 96.53
- IV
- 93.1%
- B/E move
- 6.8%
- Pseudo strike
- 93.50
- IV
- 83.7%
- B/E move
- 5.0%
50Δ
- Pseudo strike
- 94.81
- IV
- 90.7%
- B/E move
- 5.5%
- Pseudo strike
- 94.79
- IV
- 87.4%
- B/E move
- 4.4%
55Δ
- Pseudo strike
- 93.31
- IV
- 90.6%
- B/E move
- 4.8%
- Pseudo strike
- 96.28
- IV
- 88.0%
- B/E move
- 3.8%
60Δ
- Pseudo strike
- 91.82
- IV
- 90.5%
- B/E move
- 4.0%
- Pseudo strike
- 97.82
- IV
- 87.9%
- B/E move
- 3.2%
65Δ
- Pseudo strike
- 90.33
- IV
- 90.4%
- B/E move
- 3.3%
- Pseudo strike
- 99.35
- IV
- 87.8%
- B/E move
- 2.6%
70Δ
- Pseudo strike
- 88.66
- IV
- 90.6%
- B/E move
- 2.7%
- Pseudo strike
- 101.33
- IV
- 89.7%
- B/E move
- 2.1%
75Δ
- Pseudo strike
- 86.94
- IV
- 90.8%
- B/E move
- 2.1%
- Pseudo strike
- 103.63
- IV
- 93.0%
- B/E move
- 1.7%
80Δ
- Pseudo strike
- 85.23
- IV
- 91.1%
- B/E move
- 1.6%
- Pseudo strike
- 106.45
- IV
- 97.0%
- B/E move
- 1.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 52.87% | |
| 53.60% | |
| 53.85% | |
| 55.46% | |
| 55.80% | |
| 55.96% | |
| 56.28% | |
| 56.84% | |
| 57.36% | |
| 58.05% |
Biotechnology
MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral,…
More →MLTX
MoonLake Immunotherapeutics is an innovative biotechnology firm dedicated to advancing therapies for chronic inflammatory diseases through its proprietary drug delivery…
More →MLYS
Description unavailable
More →MNKD
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United…
More →MPLT
Description unavailable
More →MRNA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases,…
More →